SCHEMBL13049464

SCHEMBL13049464

C[C@@H]1NC(=O)NC1CCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 8/20 1.00
RIN1 Q13671 8/20 1.00
PPARG P37231 5/20 1.00
NR2E3 Q9Y5X4 3/20 1.00
NCOR2 Q9Y618 2/20 1.00
IDE P14735 2/20 1.00
TDP1 Q9NUW8 11/20 0.97
ALDH1A1 P00352 5/20 0.58
NSD2 O96028 3/20 0.58
MAPK10 P53779 2/20 0.58
MAPK1 P28482 2/20 0.58
HSD17B10 Q99714 2/20 0.58
L3MBTL1 Q9Y468 3/20 0.57
HPGD P15428 1/20 0.57
TAAR1 Q96RJ0 1/20 0.57
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13079427 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL14956497 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL143997 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL9037713 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL143996 1.00 ABL1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
Ammonia Solution, Strong SCHEMBL5943165 0.98 ABL1 (0.97) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL19739348 0.98 ABL1 (0.97) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL9601528 0.98 TDP1 (1.00) ABL1RIN1PPARGNR2E3NCOR2
SCHEMBL381614 0.94 ABL1 (0.88) ABL1RIN1PPARGNR2E3NCOR2
Thiosulfuric Acid SCHEMBL6499597 0.91 ABL1 (0.83) ABL1RIN1PPARGNR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 ABL1 2541/4885RIN1 222/4885PPARG 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.